| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;110:928-933.)
© 2004 American Heart Association, Inc.
Original Articles |
From the Department of Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea; and the Cardiovascular Research Foundation, New York, NY (G.S.M.).
Correspondence to Seung-Jung Park, MD, PhD, Departments of Medicine, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Poongnap-dong, Songpa-gu, Seoul, 138-736, Korea. E-mail sjpark{at}amc.seoul.kr
Received December 10, 2003; de novo received February 25, 2004; revision received April 20, 2004; accepted April 22, 2004.
| Abstract |
|---|
|
|
|---|
Methods and Results We performed 3-vessel intravascular ultrasound (IVUS) examination in 235 patients: 122 had AMI, and 113 had SAP. Plaque rupture of infarct-related or target lesions occurred in 80 AMI patients (66%) and in 31 SAP patients (27%) (P<0.001). Noninfarct-related or nontarget artery plaque ruptures occurred in 21 AMI patients (17%) and 6 SAP patients (5%) (P=0.008). Multiple plaque ruptures were observed in 24 AMI (20%) and 7 SAP patients (6%) (P=0.004). Therefore, at least 1 plaque rupture in any coronary artery was noted in 84 AMI patients (69%) and 35 SAP patients (31%) (P<0.001). Overall, the only independent clinical predictor of plaque rupture in the infarct-related/target lesion was AMI (P<0.01; OR, 4.867; 95% CI, 2.734 to 8.661). The only independent clinical predictor of plaque rupture in AMI patients was an elevated C-reactive protein (CRP) level (P=0.035; OR, 2.139; 95% CI, 1.053 to 4.343). Conversely, in SAP patients, the only independent clinical predictor of plaque rupture was diabetes mellitus (P=0.034; OR, 2.553; 95% CI, 1.071 to 6.085). The only independent clinical predictor of multiple plaque ruptures was AMI (P=0.003; OR, 3.752; 95% CI, 1.546 to 9.105).
Conclusions Three-vessel IVUS imaging showed that culprit lesion plaque rupture, secondary remote plaque ruptures, and multiple plaque ruptures were all more common in AMI patients than SAP patients. In AMI patients, plaque rupture was associated with a high CRP level, whereas in SAP patients, plaque rupture was more common in those with diabetes.
Key Words: ultrasonics plaque coronary artery disease
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
|
AMI was defined as continuous chest pain at rest with abnormal levels of cardiac enzymes (creatinine kinase-MB or troponin-T); 91 patients had ST-segment elevation (>0.1 mV in 2 contiguous ECG leads), and 31 patients did not. Seventy-one of 91 patients with ST-segment elevation underwent primary stenting within 12 hours of symptom onset. Ten patients with ST-segment elevation who underwent primary thrombolytic treatment, 10 patients with ST-segment elevation who arrived at the emergency room >12 hours after symptom onset, and 31 patients without ST-segment elevation underwent elective stenting. Overall, the mean duration from AMI onset to IVUS was 1.4±1.9 days. Platelet glycoprotein IIb/IIIa receptor inhibitors were used in 22 patients (18%). Multivessel interventions were performed in 34 AMI patients (28%).
SAP was defined as no change in frequency, duration, or intensity of symptoms within 6 weeks before the intervention.9 None of the SAP patients received platelet glycoprotein IIb/IIIa receptor inhibitors. Multivessel interventions were performed in 29 SAP patients (26%).
The infarct-related or target lesion was identified by the combination of left ventricular wall motion abnormalities, ECG findings, angiographic lesion morphology, and scintigraphic defects. In SAP patients treated with multivessel intervention, lesions with more severe diameter stenosis and more complex lesion morphology in the vessel territory of scintigraphic reversible defects were selected as the target lesions.
Serum samples were collected just before coronary intervention and IVUS (1.4±1.9 days after symptom onset). C-reactive protein (CRP) was measured by use of a high-sensitivity turbidimetric assay with a coefficient of variation of <5% (hs-CRP, Cobas Integra, Roche Diagnostics). The low detection threshold of this method is 0.0064 mg/dL.10
Other standard risk factors were assessed. Diabetic patients were defined as those undergoing treatment with oral hypoglycemic agents or insulin at study entry.
IVUS Imaging and Analysis
IVUS examinations of all 3 major epicardial arteries were performed before any intervention and after intracoronary administration of 0.2 mg nitroglycerin using a motorized transducer pullback system (0.5 mm/s) and a commercial scanner (Boston Scientific Corp/SCIMED) consisting of a rotating 30-MHz transducer within a 3.2F imaging sheath. Qualitative and quantitative analyses were performed according to criteria of the American College of Cardiologys Clinical Expert Consensus Document on IVUS.11
IVUS signs of plaque rupture suggested that a ruptured plaque contained a cavity that communicated with the lumen with an overlying residual fibrous cap fragment.7 The diagnosis of plaque rupture required independent review and agreement by 2 of the authors (M.-K.H. and Y.-H.K.). Figure 1 shows a typical plaque rupture. A fissure without a cavity communicating with the true lumen was not included in the analysis. Identification of 2 separate plaques in the same artery (ie, infarct-related/target lesion versus noninfarct-related/target lesion) required a
5-mm reference segment between them; if not, they were considered to be part of one long lesion.7 The intraplaque cavity was measured and extrapolated to the ruptured capsular area.6
|
Quantitative IVUS analysis was performed by use of computerized planimetry at the infarct-related or target lesion and proximal and distal reference segments. The reference segments were the most normal-looking cross sections within 5 mm proximal and distal to the lesion but before any side branch. Quantitative measurements included external elastic membrane (EEM), lumen, and plaque and media (P and M=EEM minus lumen) cross-sectional area (CSA). A remodeling index was calculated as the lesion EEM CSA divided by the mean reference EEM CSA. Expansive (or positive) remodeling was defined as a remodeling index >1.0.11
Quantitative Coronary Angiographic Analysis
Using the guiding catheter for magnification-calibration and an online system (ANCOR V2.0, Siemens), minimal luminal diameters (MLDs) of the infarct-related/target-lesion-segment and reference-segment lumen diameters were measured before coronary intervention.
Statistical Analysis
Statistical analysis was performed with SPSS program. Data are presented as frequencies or mean±SD. Comparison was performed with a Pearsons
2 or Fishers exact test and unpaired Students t test or ANOVA. Multivariate logistic regression analysis was performed to assess independent clinical predictors for plaque rupture of the infarct-related/target lesion or multiple plaque ruptures. A probability value of P<0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
|
Infarct-related lesion plaque rupture was found in 80 AMI patients (66%), and target lesion plaque rupture occurred in 31 SAP patients (27%) (P<0.001). There was at least 1 noninfarct-related artery plaque rupture in 21 AMI patients (17%), and in 6 SAP patients, there was at least 1 plaque rupture in a nontarget artery (5%) (P=0.008). Multiple plaque ruptures were observed in 24 AMI patients (20%) and 7 SAP patients (6%) (P=0.004). Therefore, at least 1 plaque rupture in any coronary artery was noted in 84 AMI patients (69%) and 35 SAP patients (31%) (P<0.001) (Figure 2). The EEM, lumen, and ruptured-plaque cavity CSA were 16.3±4.9, 5.4±2.4, and 2.0±0.7 mm2 in noninfarct-related ruptured plaque and 16.5±6.4, 5.7±2.6, and 1.9±1.2 mm2 in nontarget ruptured plaque, respectively.
|
In AMI patients, the incidence of infarct-related lesions and secondary plaque ruptures were similar among the 3 different subgroups (Table 3).
|
Clinical characteristics, QCA measurements, and IVUS findings comparing SAP patients with and without target lesion plaque rupture are shown in Table 4. The group with SAP and plaque rupture had more diabetes, larger QCA reference diameters, and larger IVUS reference EEM and lumen CSA and lesion site EEM CSA than the group with SAP and no plaque rupture. A similar analysis of AMI patients showed that those with plaque rupture had higher CRP levels, larger IVUS reference and lesion site EEM CSA, more expansive lesion site remodeling, and larger QCA and IVUS reference lumen dimensions (Table 5).
|
|
Multivariate logistic regression analysis was performed to determine the independent clinical predictors of infarct-related or target lesion plaque rupture. All clinical variables with a value of P<0.2 in univariate analysis were tested. In the entire cohort of 235 patients, the only independent predictor of plaque rupture was AMI (P<0.01; OR, 4.867; 95% CI, 2.734 to 8.661). In AMI patients, the only independent predictor of plaque rupture was elevated CRP level (P=0.035; OR, 2.139; 95% CI, 1.053 to 4.343). In SAP patients, the only independent predictor was diabetes mellitus (P=0.034; OR, 2.553; 95% CI, 1.071 to 6.085). The only independent predictor of multiple plaque ruptures was AMI (P=0.003; OR, 3.752; 95% CI, 1.546 to 9.105).
| Discussion |
|---|
|
|
|---|
Retrospective pathological studies of patients with coronary artery disease who died suddenly showed culprit lesion plaque rupture in
70% of patients.1,2,12,13 IVUS studies have reported varying frequencies of infarct-related plaque rupture in AMI patients: 15.8% by Kotani et al,7 37.5% by Rioufol et al,6 37% by Fukuda et al,8 and 55.6% by Sano et al.14 The time from symptom onset to IVUS imaging was <7 days,7 <4 weeks,6 <10 hours,8 and <6 hours,14 respectively. In the present study, plaque rupture was observed in 66% of AMI patients; the time from symptom onset to IVUS imaging was 1.4±1.9 days. The interval from symptom onset to IVUS imaging might, in part, explain the differences among these studies.7 There are no currently recognized IVUS features of plaque erosion. Thus, whether nonruptured culprit lesions in AMI patients represent plaque erosion, misdiagnosis, or thrombus obscuring the rupture cavity is not clear. However, it is notable that in the present study, expansive remodeling was less frequent in nonruptured AMI lesions, a finding that has also been seen pathologically in infarct-related erosions.15
One angioscopic study reported that plaque rupture and subsequent thrombus formation were observed in 17% of SAP patients.16 In the present study, 27% of SAP patients had plaque rupture.
Multiple Plaque Ruptures
Goldstein et al,3 in angiography studies, Buffon et al,17 measuring neutrophil myeloperoxidase, and Asakura et al,18 in angioscopic studies, found multiple yellow plaques in a wide range of cardiovascular patient populations.12 In particular, Goldstein et al3 found multiple complex angiographic plaques in 100 of 253 AMI patients. Two recent IVUS studies reported the frequency of multiple plaque ruptures in ACS/AMI patients: 79% in the only reported 3-vessel IVUS study6 and 19% when studying just the infarct-related artery.19 Histopathological studies have classically found more than 2 plaque ruptures per AMI patient.2 This study population had primarily angiographic 1-vessel disease. Compared with Western patients, Korean patients have less extensive reference segment atherosclerosis.20 Ruptured plaques appear to develop within the nonstenotic reference segments. These might partly explain the difference of incidence of multiple plaque ruptures between the present study (20%) and previous studies.2,6,19 However, it is also likely that not all plaque ruptures will be detectable by IVUS, because of either size, confounding IVUS morphology (thrombus may obscure the ruptures), distal location, or branch location (in the present study, only the main vessels were imaged). The present analysis refers to IVUS-detectable plaque ruptures; a more demanding technique, such as angioscopy, would probably show more rupture, as would autopsy findings.
Predictors of Plaque Rupture
AMI was an independent overall clinical predictor of plaque rupture in patients. Compared with nondiabetic patients, patients with diabetes mellitus have a worse outcome after myocardial infarction.21 Pathological study showed that coronary atherectomy specimens from diabetic patients exhibited a larger content of lipid-rich atheroma and macrophage infiltration than specimens from nondiabetic patients.22 This is consistent with a greater probability of coronary plaque rupture in diabetic patients; in the present study, diabetes mellitus was an independent predictor of plaque rupture in SAP patients. Conversely, AMI patients with and without plaque rupture had a similar incidence of diabetes mellitus. Therefore, other factors (ie, inflammatory activity) might play a major role in plaque rupture in AMI. In AMI patients in the present study, elevated CRP level was independently associated with plaque rupture. Elevated CRP level is associated with poor prognosis in ACS and may predict future risk of AMI.23,24 A recent postmortem study showed that numbers of macrophages in thin-cap atheroma were significantly greater in patients with high CRP levels than those with low CRP levels.25 One recent IVUS study showed that the presence of ruptured plaque correlated with elevated CRP levels in AMI patients.14 However, CRP levels in the present study were measured 1.4±1.9 days after the acute event. Thus, an elevated CRP level may be the consequence of IVUS-detectable plaque rupture in the AMI patients in the present study.
Limitations
Use of preintervention IVUS and the decision to perform 3-vessel IVUS was at the discretion of the operator. Therefore, the existence of selection bias cannot be completely excluded. CRP levels were obtained just before intervention in AMI patients; thus, they may reflect the acute event and not the underlying inflammatory status of the patients. However, 71 of 122 AMI patients underwent primary stenting within 12 hours of symptom onset, and the mean duration from AMI onset to IVUS was 1.4 days.
Conclusions
Three-vessel IVUS imaging showed that culprit lesion plaque rupture (66% versus 27%), secondary remote plaque ruptures (17% versus 5%), and multiple plaque ruptures (20% versus 6%) were all more common in AMI patients than SAP patients. In AMI patients, plaque ruptures were more common in patients with a high CRP level, whereas in SAP patients, plaque ruptures were more common in those with diabetes. These findings may help to establish benchmarks for approaches to diagnose and treat vulnerable or ruptured plaques in patients with coronary artery disease.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. D. Dodd, J. Rieber, E. Pomerantsev, V. Chaithiraphan, S. Achenbach, J. M. Moreiras, S. Abbara, U. Hoffmann, T. J. Brady, and R. C. Cury Quantification of Nonculprit Coronary Lesions: Comparison of Cardiac 64-MDCT and Invasive Coronary Angiography Am. J. Roentgenol., August 1, 2008; 191(2): 432 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Empana, F. Canoui-Poitrine, G. Luc, I. Juhan-Vague, P. Morange, D. Arveiler, J. Ferrieres, P. Amouyel, A. Bingham, M. Montaye, et al. Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study Eur. Heart J., July 10, 2008; (2008) ehn331v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Hong, M. H. Jeong, Y. Ahn, D. S. Sim, J. W. Chung, J. S. Cho, N. S. Yoon, H. J. Yoon, J. Y. Moon, K. H. Kim, et al. Plaque Prolapse After Stent Implantation in Patients With Acute Myocardial Infarction: An Intravascular Ultrasound Analysis J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 489 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Fischell Plaque Prolapse After Stenting in Myocardial Infarction: Bad Plaque--Bad Omen? J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 498 - 499. [Full Text] [PDF] |
||||
![]() |
T. J. Bunch, C. S. Rihal, R. J. Gumina, L. Cooper, and N. M. Caplice Progression of Nonculprit Plaque Stenosis Following Successful Percutaneous Intervention Angiology, May 1, 2008; 59(2): 236 - 239. [Abstract] [PDF] |
||||
![]() |
J. A. Ambrose In Search of the "vulnerable plaque": can it be localized and will focal regional therapy ever be an option for cardiac prevention? J. Am. Coll. Cardiol., April 22, 2008; 51(16): 1539 - 1542. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Nasu, E Tsuchikane, O Katoh, H Fujita, J-F Surmely, M Ehara, Y Kinoshita, N Tanaka, T Matsubara, Y Asakura, et al. Plaque characterisation by Virtual Histology intravascular ultrasound analysis in patients with type 2 diabetes Heart, April 1, 2008; 94(4): 429 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hemingway, C. Langenberg, J. Damant, C. Frost, K. Pyorala, and E. Barrett-Connor Prevalence of Angina in Women Versus Men: A Systematic Review and Meta-Analysis of International Variations Across 31 Countries Circulation, March 25, 2008; 117(12): 1526 - 1536. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Fukumoto, T. Hiro, T. Fujii, G. Hashimoto, T. Fujimura, J. Yamada, T. Okamura, and M. Matsuzaki Localized elevation of shear stress is related to coronary plaque rupture: a 3-dimensional intravascular ultrasound study with in-vivo color mapping of shear stress distribution. J. Am. Coll. Cardiol., February 12, 2008; 51(6): 645 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Okura, H. Taguchi, T. Kubo, I. Toda, M. Yoshiyama, J. Yoshikawa, and K. Yoshida Impact of arterial remodelling and plaque rupture on target and non-target lesion revascularisation after stent implantation in patients with acute coronary syndrome: an intravascular ultrasound study Heart, October 1, 2007; 93(10): 1219 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kusama, K. Hibi, M. Kosuge, N. Nozawa, H. Ozaki, H. Yano, S. Sumita, K. Tsukahara, J. Okuda, T. Ebina, et al. Impact of Plaque Rupture on Infarct Size in ST-Segment Elevation Anterior Acute Myocardial Infarction J. Am. Coll. Cardiol., September 25, 2007; 50(13): 1230 - 1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kubo, T. Imanishi, S. Takarada, A. Kuroi, S. Ueno, T. Yamano, T. Tanimoto, Y. Matsuo, T. Masho, H. Kitabata, et al. Assessment of Culprit Lesion Morphology in Acute Myocardial Infarction: Ability of Optical Coherence Tomography Compared With Intravascular Ultrasound and Coronary Angioscopy J. Am. Coll. Cardiol., September 4, 2007; 50(10): 933 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ohayon, O. Dubreuil, P. Tracqui, S. Le Floc'h, G. Rioufol, L. Chalabreysse, F. Thivolet, R. I. Pettigrew, and G. Finet Influence of residual stress/strain on the biomechanical stability of vulnerable coronary plaques: potential impact for evaluating the risk of plaque rupture Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1987 - H1996. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Waxman, F. Ishibashi, and J. E. Muller Detection and Treatment of Vulnerable Plaques and Vulnerable Patients: Novel Approaches to Prevention of Coronary Events Circulation, November 28, 2006; 114(22): 2390 - 2411. [Full Text] [PDF] |
||||
![]() |
G. A. Rodriguez-Granillo, H. M. Garcia-Garcia, M. Valgimigli, S. Vaina, C. van Mieghem, R. J. van Geuns, M. van der Ent, E. Regar, P. de Jaegere, W. van der Giessen, et al. Global characterization of coronary plaque rupture phenotype using three-vessel intravascular ultrasound radiofrequency data analysis Eur. Heart J., August 2, 2006; 27(16): 1921 - 1927. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Elesber, C. A. Conover, A. E. Denktas, R. J. Lennon, D. R. Holmes Jr, M. T. Overgaard, M. Christiansen, C. Oxvig, L. O. Lerman, and A. Lerman Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina Eur. Heart J., July 2, 2006; 27(14): 1678 - 1684. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-E. Hassani, G. S. Mintz, H. S. Fong, S.-W. Kim, Z. Xue, A. D. Pichard, L. F. Satler, K. M. Kent, W. O. Suddath, R. Waksman, et al. Negative Remodeling and Calcified Plaque in Octogenarians With Acute Myocardial Infarction: An Intravascular Ultrasound Analysis J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2413 - 2419. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohtani, Y. Ueda, I. Mizote, J. Oyabu, K. Okada, A. Hirayama, and K. Kodama Number of Yellow Plaques Detected in a Coronary Artery Is Associated With Future Risk of Acute Coronary Syndrome: Detection of Vulnerable Patients by Angioscopy J. Am. Coll. Cardiol., June 6, 2006; 47(11): 2194 - 2200. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. DeMaria, J. Narula, E. Mahmud, and S. Tsimikas Imaging vulnerable plaque by ultrasound. J. Am. Coll. Cardiol., April 18, 2006; 47(8 Suppl): C32 - C39. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Stamper, N. J. Weissman, and M. Brezinski Plaque Characterization With Optical Coherence Tomography. J. Am. Coll. Cardiol., April 18, 2006; 47(8S): C69 - C79. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Toutouzas, M. Drakopoulou, J. Mitropoulos, E. Tsiamis, S. Vaina, M. Vavuranakis, V. Markou, E. Bosinakou, and C. Stefanadis Elevated Plaque Temperature in Non-Culprit De Novo Atheromatous Lesions of Patients With Acute Coronary Syndromes J. Am. Coll. Cardiol., January 17, 2006; 47(2): 301 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Park Inflammatory Biomarkers for Prediction of Outcomes After Unprotected Left Main Coronary Intervention Circulation, October 11, 2005; 112(15): 2226 - 2227. [Full Text] [PDF] |
||||
![]() |
M.-K. Hong, G. S. Mintz, C. W. Lee, B.-K. Lee, T.-H. Yang, Y.-H. Kim, J.-M. Song, K.-H. Han, D.-H. Kang, S.-S. Cheong, et al. The Site of Plaque Rupture in Native Coronary Arteries: A Three-Vessel Intravascular Ultrasound Analysis J. Am. Coll. Cardiol., July 19, 2005; 46(2): 261 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Narula, A. V. Finn, and A. N. DeMaria Picking Plaques That Pop ... J. Am. Coll. Cardiol., June 21, 2005; 45(12): 1970 - 1973. [Full Text] [PDF] |
||||
![]() |
A. Tanaka, K. Shimada, T. Sano, M. Namba, T. Sakamoto, Y. Nishida, T. Kawarabayashi, D. Fukuda, and J. Yoshikawa Multiple Plaque Rupture and C-Reactive Protein in Acute Myocardial Infarction J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1594 - 1599. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Libby Act Local, Act Global: Inflammation and the Multiplicity of "Vulnerable" Coronary Plaques J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1600 - 1602. [Full Text] [PDF] |
||||
![]() |
I.-K. Jang, G. J. Tearney, B. MacNeill, M. Takano, F. Moselewski, N. Iftima, M. Shishkov, S. Houser, H. T. Aretz, E. F. Halpern, et al. In Vivo Characterization of Coronary Atherosclerotic Plaque by Use of Optical Coherence Tomography Circulation, March 29, 2005; 111(12): 1551 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ambrose and D. J. D'Agate Plaque rupture and intracoronary thrombus in nonculprit vessels: An eyewitness account J. Am. Coll. Cardiol., March 1, 2005; 45(5): 659 - 660. [Full Text] [PDF] |
||||
| ||||||